Cargando…

Dimethylaminoparthenolide (DMAPT) as an alternative approach for treatment of Familial Mediterranean Fever (FMF)

OBJECTIVE(S): Familial Mediterranean Fever (FMF) is a hereditary auto-inflammatory disorder that is caused by mutations in the Mediterranean fever (MEFV) gene and is associated with an increase in pro-inflammatory cytokines, such as interleukin-1β (IL-1β) and interleukin-18 (IL-18), leading to exces...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mosayebian, Ali, Sherkat, Roya, Abediankenari, Saied, Golpour, Monireh, Rafiei, Alireza
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mashhad University of Medical Sciences 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8769508/ https://www.ncbi.nlm.nih.gov/pubmed/35096301 http://dx.doi.org/10.22038/IJBMS.2021.59180.13140

Ejemplares similares

Familial Mediterranean Fever (FMF) before the age of one year
por: Delion, F, et al.
Publicado: (2008)

Rheumatoid Arthritis and Familial Mediterranean Fever or Sacroiliitis Accompanied by FMF
por: Şahin, Ali, et al.
Publicado: (2013)

Update on the management of colchicine resistant Familial Mediterranean Fever (FMF)
por: El Hasbani, Georges, et al.
Publicado: (2019)

The effectiveness of Colchicine as an anti-inflammatory drug in the treatment of coronavirus disease 2019: Meta-analysis
por: Golpour, Monireh, et al.
Publicado: (2021)

How long is the diagnosis of Familial Mediterranean Fever (FMF) delayed in a region where FMF is common in Turkey?
por: Karaaslan, Y, et al.
Publicado: (2015)

Attacks of severe dysmenorrhea as the sole manifestation of Familial Mediterranean Fever (FMF)
por: Vitale, A, et al.
Publicado: (2008)

The patient experience of Colchicine Resistant-Familial Mediterranean Fever (cr-FMF)
por: Dandekar, P, et al.
Publicado: (2015)

Behçet Disease (BD) in two siblings affected with Familial Mediterranean Fever (FMF)
por: Calcagno, G, et al.
Publicado: (2008)

Familial Mediterranean Fever in Iran: A Report from FMF Registration Center
por: Salehzadeh, Farhad
Publicado: (2015)

Epidemiology of colchicine resistant Familial Mediterranean Fever disease (CrFMF) in Turkey
por: Turgay, S, et al.
Publicado: (2015)

Gut Microbiota between Environment and Genetic Background in Familial Mediterranean Fever (FMF)
por: Di Ciaula, Agostino, et al.
Publicado: (2020)

Familial Mediterranean Fever (FMF) and renal disease: first report on 29 Sicilian patients
por: Vitale, A, et al.
Publicado: (2008)

The endogenous TLR-4 ligands MRP8/14 as biomarkers of inflammation in Familial Mediterranean Fever (FMF)
por: Wittkowski, H, et al.
Publicado: (2008)

Killer Cell Immunoglobulin-Like Receptor (KIR) Genotype Distribution in Familial Mediterranean Fever (FMF) Patients
por: Erken, Ertugrul, et al.
Publicado: (2015)

Prevalence of Mediterranean fever gene mutations in clinically suspected FMF patients in Algeria
por: Ait-Idir, D, et al.
Publicado: (2015)

The familial Mediterranean fever (FMF) 50 score: does it work in a controlled clinical trial? Re-analysis of the trial of rilonacept for patients with colchicine resistant or intolerant FMF
por: Hashkes, P, et al.
Publicado: (2015)

Differential expression of miR-4520a is associated with gain of function mutations in Familial Mediterranean Fever (FMF)
por: Latsoudis, H, et al.
Publicado: (2015)

Rilonacept (IL-1 TRAP) for treatment of colchicine resistant familial mediterranean fever (FMF): a randomized, multicenter double-blinded, alternating treatment trial
por: Hashkes, PJ, et al.
Publicado: (2011)

Chronic destructive arthritis as an isolated symptom of familial Mediterranean fever (FMF) in a 17 year old Turkish boy
por: Dueckers, G, et al.
Publicado: (2011)

Genetic Profile of Patients with Familial Mediterranean Fever (FMF): Single Center Experience at King Hussein Medical Center (KHMC)
por: Habahbeh, Lana Ayesh, et al.
Publicado: (2015)

Compliance to colchicine treatment and disease activity in Familial Mediterranean Fever (FMF) patients in Middle/Black Sea Region of Turkey (in Çorum region)
por: Karaaslan, Y, et al.
Publicado: (2015)

Connectivity mapping of glomerular proteins identifies dimethylaminoparthenolide as a new inhibitor of diabetic kidney disease
por: Klein, Julie, et al.
Publicado: (2020)

Secondary amyloidosis in a patient carrying mutations in the familial Mediterranean fever (FMF) and tumour necrosis factor receptor-1 syndrome (TRAPS) genes
por: Clementi, Anna, et al.
Publicado: (2013)

Dapsone as an Alternative Therapy in Children with Familial Mediterranean Fever
por: Salehzadeh, Farhad, et al.
Publicado: (2012)

Parthenolide and DMAPT induce cell death in primitive CML cells through reactive oxygen species
por: Flores‐Lopez, Gabriela, et al.
Publicado: (2018)

The Perspective of Therapeutic Antibody Marketing in Iran: Trend and Estimation by 2025
por: Golpour, Monireh, et al.
Publicado: (2021)

Dimethylaminoparthenolide and gemcitabine: a survival study using a genetically engineered mouse model of pancreatic cancer
por: Yip-Schneider, Michele T, et al.
Publicado: (2013)

NF-κB-dependent and -independent epigenetic modulation using the novel anti-cancer agent DMAPT
por: Nakshatri, H, et al.
Publicado: (2015)

Kawasaki disease and familial mediterranean fever gene mutations, is there any link?
por: Salehzadeh, Farhad, et al.
Publicado: (2019)

FMF is not always “fever”: from clinical presentation to “treat to target”
por: Maggio, Maria Cristina, et al.
Publicado: (2020)

Familial Mediterranean Fever without Fever
por: Hotta, Yuma, et al.
Publicado: (2020)

FMF: an update
por: Ozen, Seza
Publicado: (2014)

P01-043 – Comparative characteristic of FMF and FMF with HSP
por: Sargsyan, H, et al.
Publicado: (2013)

Familial Mediterranean Fever and Hypercoagulability
por: Tayer-Shifman, Oshrat E., et al.
Publicado: (2011)

An Update on Familial Mediterranean Fever
por: Lancieri, Maddalena, et al.
Publicado: (2023)

Mevalonate kinase deficiency/Hyperimmunoglobulin D syndrome (MVK/HIDS) in a Differential Diagnosis of Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Cervical Adenitis (PFAPA) Syndrome and Familial Mediterranean Fever (FMF): A Case Report
por: Aktaş, Berkay, et al.
Publicado: (2022)

Cold Atmospheric Plasma Is a Potent Tool to Improve Chemotherapy in Melanoma In Vitro and In Vivo †
por: Alimohammadi, Mina, et al.
Publicado: (2020)

Parthenolide and DMAPT exert cytotoxic effects on breast cancer stem-like cells by inducing oxidative stress, mitochondrial dysfunction and necrosis
por: Carlisi, D, et al.
Publicado: (2016)

NF-κB inhibition by dimethylaminoparthenolide radiosensitizes non-small-cell lung carcinoma by blocking DNA double-strand break repair
por: Deraska, Peter V., et al.
Publicado: (2018)

Familial Mediterranean Fever in older children
por: Özdel, Semanur, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_e07no9jk6gh5u24tack03dentl